Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-19 09:00 am Sale | 13D | Revance Therapeutics Inc. RVNC | Teoxane SA | 0 0.000% | -6,550,800 (Position Closed) | View |
| 2024-10-23 7:17 pm Sale | 13G | Revance Therapeutics Inc. RVNC | GIC Private Ltd | 0 0.000% | -5,825,881 (Position Closed) | View |
| 2024-10-07 10:08 am Sale | 13G | Revance Therapeutics Inc. RVNC | Capital World Investors | 0 0.000% | -6,948,769 (Position Closed) | View |
| 2024-09-16 5:01 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | Beryl Capital Management LLC | 1,642,448 1.600% | 1,642,448 (New Position) | View |
| 2024-09-09 10:40 am Sale | 13G | Revance Therapeutics Inc. RVNC | Capital World Investors | 6,948,769 6.600% | -4,990,307 (-41.80%) | View |
| 2024-04-09 1:17 pm Sale | 13G | Revance Therapeutics Inc. RVNC | JPMORGAN CHASE & CO JPM | 2,768,691 2.600% | -1,986,080 (-41.77%) | View |
| 2024-02-14 4:55 pm Sale | 13G | Revance Therapeutics Inc. RVNC | Palo Alto Investors LP | 5,237,284 5.960% | -46,325 (-0.88%) | View |
| 2024-02-14 3:45 pm Sale | 13G | Revance Therapeutics Inc. RVNC | Antara Capital LP | 0 0.000% | -5,239,600 (Position Closed) | View |
| 2024-02-13 5:13 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | VANGUARD GROUP INC | 5,069,625 5.770% | 573,309 (+12.75%) | View |
| 2024-02-13 09:39 am Sale | 13G | Revance Therapeutics Inc. RVNC | Polar Capital Holdings Plc | 3,169,239 3.600% | -1,679,394 (-34.64%) | View |
| 2024-02-09 6:21 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | Capital World Investors | 11,939,076 13.600% | 2,458,920 (+25.94%) | View |
| 2024-02-09 10:05 am Purchase | 13G | Revance Therapeutics Inc. RVNC | GIC Private Ltd | 5,825,881 6.630% | 332,916 (+6.06%) | View |
| 2024-02-06 1:58 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | FRANKLIN RESOURCES INC BEN | 6,108,277 6.800% | 4,352,414 (+247.88%) | View |
| 2024-01-25 1:48 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | BlackRock Inc. BLK | 7,453,371 8.500% | 380,690 (+5.38%) | View |
| 2024-01-25 11:11 am Unchanged | 13G | Revance Therapeutics Inc. RVNC | JPMORGAN CHASE & CO JPM | 4,754,771 5.400% | 0 (Unchanged) | View |
| 2024-01-25 11:10 am Sale | 13G | Revance Therapeutics Inc. RVNC | JPMORGAN CHASE & CO JPM | 4,754,771 5.400% | -228,178 (-4.58%) | View |
| 2023-10-24 4:05 pm Purchase | 13D | Revance Therapeutics Inc. RVNC | Teoxane SA | 6,550,800 7.400% | 2,105,000 (+47.35%) | View |
| 2023-09-01 09:12 am Purchase | 13D | Revance Therapeutics Inc. RVNC | Teoxane SA | 4,445,800 5.000% | 4,445,800 (New Position) | View |
| 2023-02-14 4:22 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | Palo Alto Investors LP | 5,283,609 6.420% | 914,243 (+20.92%) | View |
| 2023-02-14 4:02 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | Polar Capital Holdings Plc | 4,848,633 5.900% | 4,848,633 (New Position) | View |